Skip to content

A clinical study on the effect of An Ayurvedic compound (Medhya Churna) in Cigarette smoking cessation

A Single arm open labelled clinical study on the effect of Medhya Churna in cigarette smoking cessation with special reference to Atatwabhinivesha - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027241
Enrollment
50
Registered
2020-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

Intervention1: Medhya Churna: 2g of the trial drug (Equal quantities of powders of dried whole plant of Shankhupuhpi and dried roots of Ashwagandha) will be administered orally with hot water at 6 am

Sponsors

RGUHS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who voluntarily wishes to stop smoking Quantity of Cigarette smoked 5-10/Day Subjects are selected irrespective of Sex, Religion, and Socio-economic Status

Exclusion criteria

Exclusion criteria: Subjects who are under NRT or any therapy or medicines for smoking cessation Co-existing major systemic disorders Participants with any other psychiatric illness. Participants taking other psychiatric medicines

Design outcomes

Primary

MeasureTime frame
Assessment will be done based on subjective and objective criteria before, during and after the treatment with Assessment Tool Fragerstorm Test for Nicotine Dependence (FTND) and Objective parameter of Rapid Nicotine or Cotinine testTimepoint: 1.Base line, Before treatment ( On First day) 2. On 21st Day 3. After treatment (On 42nd Day) 4. After Follow-up period (On 84th day)

Secondary

MeasureTime frame
No of patient quit smoking during the study period Effect of padamshika krama in smoking cessationTimepoint: Time of assessment: 1. Before treatment ( On First day) 2. On 21st Day 3. After treatment (On 42nd Day) 4. After Follow-up period (On 84th day)

Countries

India

Contacts

Public ContactDr Hrishikesh O K MD AYU

JSS Ayurvedic Medical College And Hospital

hrishikeshok@gmail.com8547079574

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026